105 related articles for article (PubMed ID: 10769643)
1. Expression of the mismatch repair protein hMSH2 in carcinoma in situ and invasive cancer of the breast.
Bock N; Meden H; Regenbrecht M; Jünemann B; Wangerin J; Marx D
Anticancer Res; 2000; 20(1A):119-24. PubMed ID: 10769643
[TBL] [Abstract][Full Text] [Related]
2. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
Naidu R; Wahab NA; Yadav MM; Kutty MK
Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
[TBL] [Abstract][Full Text] [Related]
3. Analysis of hMSH2 mismatch repair protein expression in dysplasia, carcinoma in situ and invasive squamous cell carcinoma of the vocal folds.
Hussein MR; Aref EE; Yassen DG; Ramadan MO
Cancer Invest; 2009 Jan; 27(1):38-46. PubMed ID: 19160096
[TBL] [Abstract][Full Text] [Related]
4. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.
Leach FS; Hsieh JT; Molberg K; Saboorian MH; McConnell JD; Sagalowsky AI
Cancer; 2000 May; 88(10):2333-41. PubMed ID: 10820356
[TBL] [Abstract][Full Text] [Related]
5. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
6. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas.
Vakkala M; Kahlos K; Lakari E; Pääkkö P; Kinnula V; Soini Y
Clin Cancer Res; 2000 Jun; 6(6):2408-16. PubMed ID: 10873093
[TBL] [Abstract][Full Text] [Related]
8. Loss of hMSH2 expression in primary breast cancer with p53 alterations.
Spagnoletti I; Pizzi C; Galietta A; Di Maio M; Mastranzo P; Daniele S; Limite G; Pettinato G; Contegiacomo A
Oncol Rep; 2004 Apr; 11(4):845-51. PubMed ID: 15010883
[TBL] [Abstract][Full Text] [Related]
9. Human mismatch repair gene (hMSH2) product expression in relation to recurrence of transitional cell carcinoma of the urinary bladder.
Jin TX; Furihata M; Yamasaki I; Kamada M; Liang SB; Ohtsuki Y; Shuin T
Cancer; 1999 Jan; 85(2):478-84. PubMed ID: 10023718
[TBL] [Abstract][Full Text] [Related]
10. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.
Jang KS; Han HX; Paik SS; Brown PH; Kong G
Cancer Lett; 2006 Dec; 244(2):203-10. PubMed ID: 16469432
[TBL] [Abstract][Full Text] [Related]
11. [Expression of mismatch repair gene hMSH2 in human malignant ovarian tumors and its clinical significance].
Ma L; Zhang J; Peng Z
Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):291-3. PubMed ID: 11775911
[TBL] [Abstract][Full Text] [Related]
12. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH
Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497
[TBL] [Abstract][Full Text] [Related]
13. Loss of Msh2 is not associated with FHIT deletion in breast carcinomas.
Yang Q; Nakamura Y; Nakamura M; Yoshimura G; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
Anticancer Res; 2002; 22(5):2591-5. PubMed ID: 12529969
[TBL] [Abstract][Full Text] [Related]
14. The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma.
Gatalica Z; Lele SM; Rampy BA; Norris BA
Cancer; 2000 Mar; 88(6):1378-83. PubMed ID: 10717620
[TBL] [Abstract][Full Text] [Related]
15. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.
Shen KL; Yang LS; Hsieh HF; Chen CJ; Yu JC; Tsai NM; Harn HJ
J Surg Oncol; 2000 Jun; 74(2):100-7. PubMed ID: 10914818
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
18. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
[TBL] [Abstract][Full Text] [Related]
19. The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP.
Leach FS; Velasco A; Hsieh JT; Sagalowsky AI; McConnell JD
J Urol; 2000 Nov; 164(5):1830-3. PubMed ID: 11025778
[TBL] [Abstract][Full Text] [Related]
20. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]